WALNUT CREEK, Calif.—JBSL-USA announced the results of a clinical study showing the weight-loss effects of its Ashitaba Chalcone powder. In the unpublished, randomized, double blind, parallel group study, 26 slightly obese male and female patients with a body mass index (BMI) between 25 and 30 took 200 mg/d of Ashitaba Chalcone as an active ingredient after dinner for eight weeks.
After the eight weeks, the researchers observed a marked reduction in the visceral and subcutaneous fat, as well as in weight, and waist and hip ratio. They noted the rate of change in visceral fat was greater than the subcutaneous fat, and attributed this to the fat-burning promotion and fat accumulation-inhibition effects of the ingredient.
“Unfortunately, obesity and its complications are on a sharp rise in the United States, among people of all ages,” said Vincent Hackel, president of JBSL-USA. “Within the sea of gimmicks, fad diets and magic pills that don’t work, our Ashitaba Chalcone powder can be an effective natural tool in combination with healthy diet and exercise to successfully address the obesity issue that most severely affects health: abundant visceral and subcutaneous fat.”
Hackel added, “Medical science has shown clearly fat—in particular the belly (visceral) fat that accumulates around the organs—secretes hormones that interrupt the healthy function of the metabolic, reproductive, circulatory and immune systems. We are confident supplements containing Ashitaba Chalcone powder can offer the public a safe option in the toolkit to dramatically reduce visceral and subcutaneous fat and weight.”